World's First Feijoa Clinical Trial Shows Early Blood Pressure Benefits

Investigating Feijoa's Active Compounds and Mechanisms

Researchers at the University of Auckland have completed the first-ever clinical trial investigating feijoa's effects on human health, revealing preliminary evidence that the fruit may help lower blood pressure. The study, conducted in New Zealand, involved participants consuming feijoa regularly over a set period while monitoring cardiovascular markers. Scientists observed a notable reduction in systolic blood pressure among those who ate the fruit compared to control groups, suggesting a potential natural approach to managing hypertension. The findings mark a significant step in understanding feijoa's role beyond its traditional use as a dietary fruit.

The trial focused on analyzing how specific compounds in feijoa, such as antioxidants and polyphenols, interact with bodily systems linked to blood pressure regulation. Participants were given controlled portions of fresh feijoa pulp, and their vascular function was assessed through non-invasive measurements. Researchers noted improvements in arterial flexibility alongside the blood pressure changes, indicating broader cardiovascular benefits. While the exact biological pathways remain under study, the team hypothesizes that feijoa's nutrient profile may support nitric oxide production, which helps relax blood vessels. Further laboratory work is planned to isolate and test individual components for their direct effects.

Could Feijoa Become Part of Dietary Guidelines for Heart Health?

If future studies confirm these initial results, feijoa might be recommended as part of heart-healthy eating patterns, particularly for individuals with prehypertension or mild hypertension. Nutrition experts caution that the fruit should complement, not replace, prescribed medications or lifestyle changes like exercise and sodium reduction. The research team emphasizes the need for larger, longer-term trials involving diverse populations to validate the findings and determine optimal consumption levels. They also aim to explore whether processed forms of feijoa retain the same benefits as fresh fruit.

What specific changes in blood pressure were observed in the trial? Participants who consumed feijoa showed an average reduction in systolic blood pressure of approximately 5-7 mmHg compared to baseline measurements, though the study was small-scale and preliminary.

Frequently Asked Questions

How much feijoa did participants eat during the study? Participants consumed about 150 grams of fresh feijoa pulp daily, equivalent to roughly two medium-sized fruits, provided in controlled portions over the trial duration.

Are there any known side effects of eating feijoa in these amounts? No adverse effects were reported during the trial; feijoa is generally considered safe for consumption, though individuals with specific allergies should exercise caution as with any new food.